Obstructive Lung Diseases Clinical Trial
Official title:
Correlation of FeNO, Blood Eosinophils, Bronchoalveolar Lavage Findings and Bronchial Epithelium Histopathology in Patients With Chronic Obstructive Pulmonary Disease and Asthma
Verified date | July 2022 |
Source | Heidelberg University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Scientific research focuses on "eosinophilic inflammation" as it seems to guide the therapeutic regimen in patients with asthma and COPD. The primary objective of this prospective trial is to evaluate which parameter(s) best reflects eosinophilic inflammation by correlating tissue eosinophils (endobronchial biopsy, protected specimen brush sampling) with FeNO, peripheral blood eosinophils, and eosinophils in the bronchoalveolar lavage of patients with obstructive pulmonary disease.
Status | Terminated |
Enrollment | 14 |
Est. completion date | January 8, 2020 |
Est. primary completion date | January 8, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with diagnosis of COPD or asthma (according to the guidelines) - Age >18 years - Indication for bronchoscopy for medical reasons (not study-related) - Ability to provide informed consent Exclusion Criteria: - paO2 <60 mmHg on 4L 02 /min, paCO2 > 55 mmHg on room air - FEV1 <20% - Pulmonary infection or exacerbation within the last 4 weeks - Additional pulmonary diseases (pneumonia, lung cancer, tuberculosis, interstitial lung disease) - Contraindication for BAL, PSB sampling or endobronchial biopsy - Current use of anticoagulants that can not be stopped for bronchoscopy - Heart failure with left ventricular ejection fraction <30% - Myocardial infarction in previous 6 months - Significant pulmonary hypertension (PAPS >45 mmHg, right heart failure [echocardiography] and/or PAPm >35 mmHg [right heart catheter]) |
Country | Name | City | State |
---|---|---|---|
Australia | Macquarie University Sydney | Sydney | New South Wales |
Germany | Division of Clinical Infectious Diseases/Research Center Borstel | Borstel | |
Germany | Thoraxklinik University Heidelberg | Heidelberg |
Lead Sponsor | Collaborator |
---|---|
Heidelberg University |
Australia, Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of eosinophilic inflammation by correlating tissue eosinophilia with eosinophil count in blood/BAL and FeNO measurement. | Correlation of FeNO, blood eosinophils, bronchoalveolar lavage findings and bronchial epithelium histopathology in patients with chronic obstructive pulmonary disease and asthma | 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05595733 -
Can NAVA Mode Reduce Mechanical Ventilation Day in Patients With COPD ?
|
N/A | |
Completed |
NCT02506504 -
Prevention of Post-exercise Muscle Fatigue and Effect on Exercise Training in Severe Patients With COPD.
|
N/A | |
Completed |
NCT02290535 -
Electrical Impedance Tomography of Lung in Child and Young Age
|
N/A | |
Active, not recruiting |
NCT02073708 -
A Population-based Investigation of Asthma in the Telemark Region of Norway
|